IRVINE, Calif., October 24, 2023 / OrthoSpineNews / – Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for bone fusion procedures, today announced the launch of its new OsteoSPAN Fiber Matrix.
Consisting of 100% demineralized cortical fibers, OsteoSPAN Fiber Matrix has been engineered for optimized handling, while providing verified osteoinductive potential and an osteoconductive scaffold that supports cellular bone formation and stimulates fusion. OsteoSPAN Fiber Matrix is also processed to provide rapid, consistent hydration and fluid retention while resisting irrigation.
The OsteoSPAN Fiber Matrix is moldable and cohesive when hydrated with blood or bone marrow, and expands to conform irregular bone voids. The product is available in 1cc, 2.5cc, 5cc and 10cc volumes.
“OsteoSPAN Fiber Matrix is Biogennix’ first allograft product,” said Biogennix CTO Mark Borden. “We’re excited to expand our portfolio to include allografts which will complement our comprehensive synthetic offering and allow us to access a new segment of the bone graft market.”
Biogennix® is a fully-integrated osteobiologics company headquartered in Irvine which develops, manufactures, and distributes proprietary bone grafting products used in bone fusion procedures. Biogennix is committed to advancing technology behind natural bone grafting solutions, delivering outstanding quality with exceptional value, and customer-focused excellence. Learn more at biogennix.com.